Switch to:
More From Other Websites
Pfizer to shutter vaccines sales business in China Apr 02 2015
Pfizer Says Ceasing Vaccine Commercial Operations in China Apr 01 2015
Cramer: Huge pharma opportunity for women's health Apr 01 2015
Analyzing Pfizer’s Research and Development Apr 01 2015
Wave Of Biosimilars Set To Roil Pharma Apr 01 2015
The 4 Stocks That Dragged the DJIA Down on Wednesday Apr 01 2015
Hedge Funds Made A Bundle By Betting On Amazon.com, Inc. (AMZN), Apple, and Pfizer Inc Apr 01 2015
Why Is Pfizer’s Revenue Stream Declining? Apr 01 2015
What are examples of major companies in the drugs sector? Apr 01 2015
Apple, United Health may be winners this earnings season Apr 01 2015
Pfizer’s Global Established Pharmaceutical Segment Apr 01 2015
U.S. Drugmakers Facing First Wave Of Biosimilars Apr 01 2015
Has Lack Of Revenue Growth Stunted Pharma R&D Investments? Apr 01 2015
Our Take on the First Quarter Apr 01 2015
Ascend Capital Opens New Position in Gilead Sciences Mar 31 2015
Cramer: Problem feeding all investing decisions now Mar 31 2015
Pfizer’s Global Vaccines, Oncology & Consumer Healthcare Segment Mar 31 2015
Personalized medicine a factor in Quintiles-Quest JV Mar 31 2015
Metaldyne Performance Group Inc (MPG): Levin Capital’s Latest Move and its Top Three Picks Mar 31 2015
Pfizer’s Global Innovative Pharmaceutical Segment Mar 31 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 9 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK